Frontiers in immunology

mRNA vaccines for lung cancer that change the tumor environment to boost immune response

Updated

Abstract

mRNA vaccines may induce durable anti-tumor immune responses in lung cancer treatment.

  • Tumor vaccines aim to activate immune responses against lung cancer, addressing limitations of traditional therapies.
  • Recent advancements in mRNA vaccine technology show promise for rapid development and production.
  • These vaccines work by delivering mRNA that encodes tumor-specific antigens, reshaping the tumor microenvironment.
  • The reshaping of the tumor environment occurs through direct modulation and T-cell activation pathways.
  • Current research focuses on optimizing delivery systems and identifying novel tumor antigens and immune biomarkers.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free